Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris

ClinicalTrials.gov ID: NCT02413346

Public ClinicalTrials.gov record NCT02413346. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 7:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Open-label study will evaluate the safety of an approximate 1.5 mg/kg/day dose of oral sarecycline in the long-term treatment of participants with moderate to severe facial acne vulgaris.

Study identification

NCT ID
NCT02413346
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Almirall, S.A.
Industry
Enrollment
490 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
9 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 20, 2015 (Actual)
Primary completion
Aug 26, 2016 (Actual)
Completion
Aug 26, 2016 (Actual)
Last update posted
Feb 1, 2019

2015 – 2016

United States locations

U.S. sites
56
U.S. states
23
U.S. cities
49
Facility City State ZIP Site status
Actavis Investigational Study Site #206 Mobile Alabama 36608 —
Actavis Investigational Study Site #236 Hot Springs Arkansas 71913 —
Actavis Investigational Study Site #245 Carlsbad California 92008 —
Actavis Investigational Study Site #129 Encino California 91436 —
Actavis Investigational Study Site #209 Fremont California 94538 —
Actavis Investigational Study Site #147 Sacramento California 95819 —
Actavis Investigational Study Site #150 San Diego California 92120 —
Actavis Investigational Study Site #125 San Diego California 92123 —
Actavis Investigational Study Site #204 San Diego California 92123 —
Actavis Investigational Study Site #222 Denver Colorado 80220 —
Actavis Investigational Study Site #148 Wheat Ridge Colorado 80033 —
Actavis Investigational Study Site #226 Clearwater Florida 33761 —
Actavis Investigational Study Site #238 Jupiter Florida 33458 —
Actavis Investigational Study Site #249 Miami Florida 33142 —
Actavis Investigational Study Site #145 Miami Florida 33175 —
Actavis Investigational Study Site #211 Miramar Florida 33207 —
Actavis Investigation Study Site # 140 North Miami Beach Florida 33162 —
Actavis Investigational Study Site #151 Orange Florida 32073 —
Actavis Investigational Study Site #203 Tampa Florida 33609 —
Actavis Investigational Study Site #242 Snellville Georgia 30078 —
Actavis Investigational Study Site #124 Boise Idaho 83704 —
Actavis Investigational Study Site #106 Chicago Illinois 60611 —
Actavis Investigational Study Site #113 South Bend Indiana 46617 —
Actavis Investigational Study Site #213 Louisville Kentucky 40202 —
Actavis Investigational Study Site #217 Rockville Maryland 20850 —
Actavis Investigational Study Site #251 Clarkston Michigan 48346 —
Actavis Investigational Study Site #235 Clinton Township Michigan 48038 —
Actavis Investigational Study Site #227 Fort Gratiot Michigan 48059 —
Actavis Investigational Study Site #111 Warren Michigan 48088 —
Actavis Investigational Study Site #221 Fridley Minnesota 55432 —
Actavis Investigational Study Site #231 Omaha Nebraska 68144 —
Actavis Investigational Study Site #146 New York New York 10016 —
Actavis Investigational Study Site #208 New York New York 10155 —
Actavis Investigational Study Site #240 Rochester New York 14623 —
Actavis Investigational Study Site #230 Stony Brook New York 11790 —
Actavis Investigational Study Site #229 Raleigh North Carolina 27612 —
Actavis Investigational Study Site #149 Gresham Oregon 97030 —
Actavis Investigational Study Site #257 Philadelphia Pennsylvania 19103 —
Actavis Investigational Study Site #225 Goodlettsville Tennessee 37072 —
Actavis Investigational Study Site #128 Knoxville Tennessee 37917 —
Actavis Investigational Study Site #216 Knoxville Tennessee 37922 —
Actavis Investigational Study Site #109 Nashville Tennessee 37215 —
Actavis Investigational Study Site #223 Arlington Texas 76011 —
Actavis Investigational Study Site #252 Arlington Texas 76011 —
Actavis Investigational Study Site #220 College Station Texas 77845 —
Actavis Investigational Study Site #104 Dallas Texas 75234 —
Actavis Investigational Study Site #142 Houston Texas 77004 —
Actavis Investigational Study Site #105 Houston Texas 77056 —
Actavis Investigational Study Site #201 Katy Texas 77494 —
Actavis Investigational Study Site #223 Pflugerville Texas 78660 —
Actavis Investigational Study Site #101 Plano Texas 75093 —
Actavis Investigational Study Site #207 San Antonio Texas 78218 —
Actavis Investigational Study Site #212 West Jordan Utah 84088 —
Actavis Investigational Study Site #244 Norfolk Virginia 23507 —
Actavis Investigational Study Site #144 Spokane Washington 99202 —
Actavis Investigational Study Site #233 Walla Walla Washington 99362 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02413346, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 1, 2019 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02413346 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →